Journals / Türk Kolon ve Rektum Hastalıkları Dergisi / 2020 / Cilt: 30 - Sayı: 4

Is a Total Colectomy a Better Surgical Treatment forSpontaneous Colonic Perforation that Developedduring Bevacizumab Treatment for Extra-intestinalCancers?

Total Kolektomi, Bağırsak Dışı Kanserlerde Bevacizumab Kullanımına Bağlı Spontan Kolonik Perforasyon Tedavisinde Daha İyi Bir Cerrahi Tedavi Olabilir Mi?

Pages
319–321
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the pathophysiology of bevacizumab-related SCP, a total colectomy can be a life-saving and definitive procedure when non-perforated segments of the colon appear unhealthy during intraoperative exploration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Spontaneous colonic perforation (SCP) is a life-threatening complication of bevacizumab treatment, but data on its management is insufficient.
📊
Key Findings & Data:Patients who underwent a partial colectomy at the perforation site (n=3) suffered from ongoing abdominal sepsis postoperatively and died within a month.
💡
Conclusion & Impact:Considering the pathophysiology of bevacizumab-related SCP, a total colectomy can be a life-saving and definitive procedure when non-perforated segments of the colon appear unhealthy during intraoperative exploration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Spontaneous colonic perforation (SCP) is a life-threatening complication of bevacizumab treatment, but data on its management is insufficient. We present five cases of SCP in patients who were receiving bevacizumab for extra-intestinal malignancies. Patients who underwent a partial colectomy at the perforation site (n=3) suffered from ongoing abdominal sepsis postoperatively and died within a month. In contrast, patients who underwent total colectomy (n=2) had a relatively prolonged survival and eventually died of primary disease progression. Considering the pathophysiology of bevacizumab-related SCP, a total colectomy can be a life-saving and definitive procedure when non-perforated segments of the colon appear unhealthy during intraoperative exploration.

Özet

Spontan kolonik perforasyon, bevacizumab tedavisinin çok yüksek mortaliteyle seyreden bir komplikasyonu olmasına rağmen bu durumunyönetminine dair literatür verisi kısıtlıdır. Bu yazımızda, bağırsak dışı kanserler sebebiyle verilen Bevacizumab tedavisine sekonder gelişen beş spontankolonik perforasyon vakası sunuyoruz. Sadece perfore segmenti içerecek şekilde parsiyel kolektomi uygulanan hastalar (n=3) ilerleyen abdominalsepsis nedeniyle postop birinci ay içerisinde kaybedilmişken, total kolektomi yapılan hastalar (n=2) görece daha uzun bir sağ kalım göstermiş olupnihai olarak primer hastalığın doğal seyri sonucu kaybedilmişlerdir. Bevacizumab tedavisine bağlı spontan kolonik perforasyonun patofizyolojiside göz önünde bulundurulduğunda, total kolektomi, özellikle intraoperatif değerlendirmede kolonun perfore olmamış kısımlarının da sağlıksızgörünmesi durumunda hayat kurtarıcı ve tek basamaklı bir tedavi olabilir.

🔖

Cite This Article

DEMİR, G., HAMZAOĞLU, İ., AGHAYEVA, A., BOZKIRLI, B., DEMİR, A., AYTAC, E., KARAHASANOĞLU, T., BACA, B., BALTACI, E., ÖZBEN, V., BİLGİN, A. İ. (2022). Is a Total Colectomy a Better Surgical Treatment forSpontaneous Colonic Perforation that Developedduring Bevacizumab Treatment for Extra-intestinalCancers?. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 30 - Sayı: 4, 319–321. https://ajindex.com/articles/634547

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Avastin (bevacizumab) Information https://www.fda.gov/Drugs/ DrugSafety/ucm193900.htm 2. Roodhart JM, Langenberg MH, Witteveen E, Voest EE. The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway. Curr Clin Pharmacol 2008;3:132-143. 3. Fujii Y, Hirahara N, Kaji S, Taniura T, Hyakudomi R, Yamamoto T, Tajima Y. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature. J Med Case Rep 2018;12:84. 4. Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, Cormier JN. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 2008;19:577-582. 5. Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 2009;10:559–568. 6. Sliesoraitis S, Tawfik B. Bevacizumab-Induced Bowel Perforation. J Am Osteopath Assoc 2011;111:437-441. 7. Choi YI, Lee SH, Ahn BK, Baek SU, Park SJ, Kim YS, Shin SH. Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin). Cancer Res Treat 2008;40:33-35. 8. Freeman HJ. Colitis associated with biological agents. World J Gastroenterol 2012;18:1871-1874. 9. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, Wallace JL. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2001;281:G635-G644. 10. Borofsky SE, Levine MS, Rubesin SE, Tanyi JL, Chu CS, Lev-Toaff AS. Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients. Abdom Imaging 2013;38:265–272.